Robert H. Yolken, MD

In this Viewpoint article, Torrey et al call for the National Institute of Mental Health to expand funding for schizophrenia treatment beyond trials that focus on identified biological targets....

Exposure to infectious agents has been proposed as a risk factor in the development of serious mental illness. How is cognitive functioning affected by these agents? Does exposure to...

Probiotic compounds modulate the immune response and offer a potential treatment strategy for schizophrenia. Dickerson and colleagues performed a randomized, double-blind, placebo-controlled trial to examine whether probiotic supplementation can...